Clinical Trials in Chicago

Showing 8241-8260 of 15,574 trials

Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study

NCT04637477

This is a proof-of-concept study of a virtual version of a lifestyle intervention aimed at reducing cardiometabolic risk in patients with the Metabolic Syndrome (MetS). The aim is to recruit 12 patients at high risk for coronavirus infection based upon a diagnosis of obesity and the MetS, conduct a 12-week virtual version of the in-person intervention, and explore efficacy using clinically significant pre-specified targets for weight, diet, physical activity, stress, and markers of inflammation. In addition, the investigators will explore safety, fidelity, feasibility, and acceptability.

Metabolic SyndromeObesity

Rush University Medical Center10 participantsStarted Aug 2020

Chicago, Illinois, United States • Kansas City, Missouri, United States

COMPLETEDPhase 22.2 miles

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

NCT01966419

The purpose of this study is to determine whether ornithine phenylacetate can speed recovery from an acute hepatic encephalopathy episode requiring hospitalization in cirrhotic patients.

Acute Episode of Overt Hepatic EncephalopathyHepatic Encephalopathy

Ocera Therapeutics, Inc.231 participantsStarted Jan 2014

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +128 more locations

Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Find Trials by Condition in Chicago

A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula

Detection of COVID-19 Decompensation

Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)

Tolerance & Responsiveness Improvement for Metformin (TRIM)

Mindful Hearts Study: Mindfulness to Reduce Stress

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Real World Evidence of the Efficacy and Safety of FOQUEST

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)